Artificial Turf Cancer Lawsuit Lawsuit Tracker

Artificial turf has been installed on more than 12,000 fields across the United States — in schools, parks, recreation leagues, and professional stadiums. The playing surface relies on crumb rubber infill, a granular material manufactured from recycled car and truck tires. A landmark 2019 Yale University study analyzed the chemical composition of crumb rubber and identified 306 distinct chemical compounds. Of those, 52 are classified as known, presumed, or suspected carcinogens by both the U.S. EPA and the European Chemicals Agency. The chemicals include polycyclic aromatic hydrocarbons (PAHs), heavy metals such as lead, chromium, zinc, and cadmium, and volatile organic compounds including benzene and toluene. In 2009, University of Washington women's soccer associate head coach Amy Griffin began documenting cases of cancer among soccer players — particularly goalkeepers — who had extensive contact with crumb rubber fields. By 2016 her list had grown to 53 athletes, with a disproportionate number of blood cancers including non-Hodgkin lymphoma, leukemia, and testicular cancer. A parallel concern has emerged around PFAS — per- and polyfluoroalkyl substances — found in the synthetic turf fibers and backing material. Rain and snow leach PFAS from these fields into soil and groundwater, contributing to the same contamination pattern driving the $12.2 billion water district settlements. The litigation landscape is evolving: FieldTurf paid over $50 million in a class action settlement for defective turf, AstroTurf settled with California over lead content, and a growing number of states are enacting outright bans on PFAS-containing turf. The EPA and ATSDR completed a multi-year Federal Research Action Plan studying crumb rubber exposure, with results released through 2024 showing detectable chemical exposures though stopping short of a formal risk assessment. Legal experts compare the current trajectory to the early stages of asbestos and PFAS mass tort litigation — a period when scientific evidence was accumulating, regulatory agencies were beginning to act, and the first wave of individual lawsuits was establishing the groundwork for larger consolidated actions.